HEATHER LARSEN: Open Payments
NPI 1487021358 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 106 payments from 16 companies in 2025. Trend: 2023 $1,750 · 2024 $2,013 · 2025 $2,150
Food & beverage: $2,150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $305 |
| Madrigal Pharmaceuticals | 3 | $201 |
| Janssen Biotech, Inc. | 10 | $190 |
| GENZYME CORPORATION | 7 | $185 |
| Aimmune Therapeutics, Inc. | 7 | $166 |
| PFIZER INC. | 15 | $166 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Lilly USA, LLC | 3 | $63 |
| Novo Nordisk Inc | 3 | $59 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, REZDIFFRA, TREMFYA, ZENPEP, XELJANZ, SKYRIZI.
Industry payments across NC — which companies pay providers there.
